Archive for the ‘Blood pressure medicines’ Category

Blood pressure drugs reduce Parkinson’s risk

Thursday, February 7th, 2008

Blood pressure drugsPeople taking a certain type of blood pressure medication called calcium channel blockers may also be lowering their risk of getting Parkinson’s disease, according to a study released Wednesday.

A study by Swiss researchers found that people who had been taking a calcium channel blocker medication for an extended period of time had a 23 percent lower risk of developing the incurable neurological disease than people not on this type of drug.

The researchers also assessed several other classes of blood pressure medications, such as ACE inhibitors, AT II antagonists and beta blockers, but none of those appeared to offer the protective effect of calcium channel blockers.

“Long-term use of calcium channel blockers was associated with a reduced risk of developing Parkinson’s disease, while no such association was seen for other high blood pressure medications,” said Christoph Meier, lead author of the paper and a researcher at University Hospital Basel in Switzerland.

Meier and colleagues studied more than 7,000 men and women from the United Kingdom over the age of 40 for the study, but they did not investigate the mechanism by which the drugs lowered the risk of Parkinson’s.

Calcium channel blockers lower blood pressure by preventing calcium from entering the cells of the heart and blood vessels. The net result is that they cause blood vessels to dilate or expand, and they lead to less contraction of the heart muscle.

The class includes drugs such as Dilacor, Adalat, Cardazem, Procardia and Covera.

Parkinson’s is a chronic and progressive disorder that typically afflicts people over the age of 60. The illness stems from the loss or destruction of brain cells that produce the neurotransmitter dopamine, leading to problems with motor control.

Patients typically suffer from tremors and shakes, impaired balance and coordination and also stiffness or rigidity in the limbs or trunk.

High blood pressure medication offers reduced Parkinson’s risk

Calcium channel blockers that are used to treat high blood pressure may cut the risk of Parkinsons disease as well, say researchers.

The researchers say that their findings are based on a study of 7,374 men and women over age 40.

Christoph R. Meier of the University Hospital Basel in Switzerland has revealed half of the subjects had Parkinsons disease, while half were non-sufferers.

The studys author also revealed that nearly half of the participants in both groups used high blood pressure medications like calcium channel blockers, ACE inhibitors, AT II antagonists, and beta blockers.

It was found that people who were currently long-term users of calcium channel blockers to treat high blood pressure lowered their risk of Parkinsons disease by 23 per cent as compared to those who did not take the drugs.

No such effect was found among people taking ACE inhibitors, AT II antagonists and beta blockers.

Long-term use of calcium channel blockers was associated with a reduced risk of developing Parkinsons disease while no such association was seen for other high blood pressure medicines, said Meier.

Meier says that more research is needed to determine why calcium channel blockers appear to offer a reduced risk of Parkinsons disease, while the other high blood pressure medications do not.

Taking pills. Timing matters!

Tuesday, December 18th, 2007

PillsTaking a blood pressure pill at bedtime instead of in the morning might be healthier for some high-risk people.

New research suggests that simple switch may normalize patterns of blood pressure in patients at extra risk from the twin epidemics of heart and kidney disease.

Why? When it comes to blood pressure, you want to be a dipper. In healthy people, blood pressure dips at night, by 10 to 20 percent. Scientists don’t know why, but suspect the drop gives arteries a little rest.

People with high blood pressure that doesn’t dip at night — the non-dippers — fare worse than other hypertension sufferers, developing more serious heart disease. Moreover, heart and kidney disease fuel each other — and the 26 million Americans with chronic kidney disease seem most prone to non-dipping. In addition to heart problems, they’re at extra risk of their kidney damage worsening to the point of dialysis.

Most blood pressure patients need two or three medications. So Italian researchers performed an easy test: They told 32 non-dippers with kidney disease to switch one of those drugs from a morning to a bedtime dose. In two months, nearly 90 percent of these high-risk patients had turned into dippers. Their nighttime blood pressure dropped an average of 7 points, without side effects or increase in daytime blood pressure.

Better, a key sign of kidney function improved significantly, too, Dr. Roberto Minutolo of the Second University of Naples reports this month in the American Journal of Kidney Diseases.

It’s the latest research in the field of chronotherapy: How our bodies’ internal rhythms make certain diseases worse at certain times of the day, and in turn affect how to time treatments.

While the Italian study is too small for proof, similar studies from Europe also back a bedtime switch for non-dippers. The work is catching the attention of U.S. hypertension specialists, and now doctors at Baltimore’s Johns Hopkins University are planning a larger study to see if a bedtime switch really could give certain people healthier hearts and kidneys.

How big a problem is non-dipping?

“I think it’s huge,” says Hopkins’ Dr. Lawrence Appel. “This is our best lead” into why black Americans with kidney disease, in particular, tend to worsen despite treatment.

Appel found 80 percent of black kidney patients in a recent study were non-dippers. Most startling, 40 percent had nighttime blood pressure that was even higher than daytime levels.

Two-thirds of chronic kidney disease patients, and at least 10 percent of the general population, are estimated to be non-dippers, says Dr. Joseph Vassalotti of the National Kidney Foundation. One theory is that their bodies have trouble excreting salt.

Yet few patients have ever heard of the problem — and few doctors know who is affected. Most people get their blood pressure checked only during the day. A 24-hour blood pressure monitor can tell but is rarely used, partly because insurance seldom pays for the extra visit to download and diagnose the readings.

And most patients who take several once-a-day pills swallow them all in the morning, meaning they all start wearing off around the same time, says Dr. Gina Lundberg of St. Joseph’s Hospital in Atlanta.

“It does make good sense to take some in the morning and some in the evening,” says Lundberg, a spokeswoman for the American Heart Association.

Everyone has an internal clock, determined by genes, that affects health. Many of these biological rhythms are circadian, meaning they fluctuate on a 24-hour cycle.

Consider how that can affect the timing of treatments. Some older “statin” pills fight cholesterol best if taken at bedtime; they target a liver enzyme that’s most active at night. Asthma attacks are more frequent at night, and the stomach secretes more heartburn-causing acid at night, affecting some patients’ dosing requirements. Researchers even are studying how to better time certain cancer chemotherapies and allergy treatments.

The best-known example: Blood pressure jumps in the early morning hours, as the awakening body produces more stress hormones. That’s also why heart attacks and strokes are most common in the morning.

The nighttime dipping problem has gotten far less attention. The new Italian study marks an important advance, says Dr. Mahboob Rahman of the University Hospitals of Cleveland.

“We know now that you can change medication timing and lower blood pressure at night,” he explains.

That doesn’t mean everyone should switch willy-nilly to bedtime dosing. Morning may be best for people on just one drug, and no one yet knows if the switch truly gives non-dippers better overall health. “That’s the million-dollar question,” Rahman cautions.

Still, Lundberg says it’s worth asking your doctor how to time doses, saying one at night for someone taking multiple medicines couldn’t hurt.

See also:

Keep Timing the Tablets: Statistical Analysis of Pill Dissolution Rates Martin J. Crowder

Abstract

The way in which medicinal tablets, pills and capsules dissolve in liquid is important in the pharmaceutical industry, which collects and analyses data to assess the effects of different formulations of a medicine, different storage conditions, etc. The data usually comprise repeated measures, the record for an individual tablet consisting of either the fractions dissolved at a given sequence of time points or the times taken for given fractions to dissolve. (more…)

Blood pressure drug Telmisartan - no more strokes!

Thursday, December 13th, 2007

Telmisartan (Micardis)Telmisartan, a drug widely used to help control blood pressure, may have uniquely potent activity in preventing stroke, according to a new study conducted in an animal model.

Whether they used the drug alone or in combination with a different type of antihypertensive medication, ramipril, Weill Cornell Medical College researchers found that rats fed a high-salt, stroke-inducing diet were completely protected from the brain attacks while on telmisartan.

“No other study has ever shown complete protection against stroke in this rat model using normal human drug doses” notes study senior author Dr. Daniel F. Catanzaro, professor of physiology and biophysics and professor of physiology in cardiothoracic surgery at Weill Cornell Medical College.

The study, which was funded by telmisartan’s German maker, Boehringer Ingelheim Pharma GmbH & Co., is published online in the Journal of the American Society of Hypertension.

Telmisartan (brand name Micardis) is one of a class of widely used antihypertensive drugs known as angiotensin receptor blockers (ARBs). “These drugs primarily act on the vasculature to relax the small blood vessels,” Dr. Catanzaro explains.

Telmisartan stands out from other ARBs in that its molecular structure allows it to more easily pass through the blood-brain barrier and enter the brain — something many drugs cannot do.

The new animal study was not constructed to specifically look at telmisartan’s effect on stroke. “Because blood pressure is closely related to stroke risk, we really just wanted to look and see if combinations of antihypertensive drugs were better at lowering blood pressure and stroke compared to the use of single agents,” Dr. Catanzaro explains.

In this case, his team tested two drugs — telmisartan and an ACE inhibitor, ramipril (Altace) — in a rat model long favored by stroke researchers. In this approach, rats are fed what’s known as a “stroke-prone diet,” meaning they get lots of salt in both their food and water.

“This rat model has been great at showing us the neuroprotective properties of different drugs in the past, and the results usually correlate with results in humans,” Dr. Catanzaro says.

In the study, 25 rats were fed the stroke-prone diet for 8 weeks and received either no medication, telmisartan alone, ramipril alone, or the two drugs together at either full- or half-doses.

“A main finding was that combination therapy did reduce blood pressure the best of any treatment, and it also was best at cutting damage to the rats’ hearts and kidneys,” Dr. Catanzaro says. “But what was really surprising to us was that any regimen involving telmisartan at doses that would normally be given to humans completely prevented stroke in this model. Most studies with other drugs have used much higher doses and have found only partial protection.”

Specifically, 83 percent of rats given no medication showed signs of stroke, as did 56 percent of rats given ramipril alone. However, no strokes were noted in the telmisartan-only or the telmisartan/ramipril combo groups.

Telmisartan’s ability to easily pass through the blood-brain barrier (something ramipril cannot do) is likely behind the neuroprotective effect noted in the study, the researchers say.

“Going forward, that’s something that we would really like to test out in head-to-head trials pitting telmisartan against other ARBs, for example,” Dr. Catanzaro said. “At the same time, we’d like to examine whether telmisartan is actually getting into the brain, or if more peripheral effects — a lowering of blood pressure, for instance — are behind the reduction in stroke.”

In the meantime, Boehringer Ingelheim is nearing the end of a major clinical trial looking at the effectiveness of combining telmisartan with ramipril to lower patients’ blood pressures and reduce their odds for heart attack and stroke. Dr. Catanzaro’s team is not involved in that study.

Co-authors on this study include lead researcher Dr. Ying Zhou, as well as Dr. Fangmin Yu and Dr. Ada R. Ene — all of Weill Cornell Medical College in New York City.

Telmisartan information.

GENERIC NAME: Telmisartan
BRAND NAME: Micardis

DRUG CLASS AND MECHANISM: Telmisartan is a member of a family of drugs called angiotensin receptor blockers (ARBs), which includes losartan (Cozaar), valsartan (Diovan), irbesartan (Avapro), and candesartan (Atacand). ARBs block the ability of the chemical angiotensin II to constrict or squeeze arteries and veins. As a result, the arteries and veins enlarge and blood pressure falls. The reduced pressure in the arteries also makes it easier for the heart to pump blood. Telmisartan was approved by the FDA in November of 2000.

USES: This drug is used to treat high blood pressure (hypertension). This drug works by blocking the hormone angiotensin thereby relaxing blood vessels, causing them to widen. High blood pressure reduction helps prevent strokes, heart attacks, and kidney problems.

OTHER USES: This drug may also be used to treat congestive heart failure and to help protect the kidneys from damage due to diabetes.

HOW TO USE: Take this medication by mouth, usually once daily or as directed by your doctor. You may take this drug with or without food. Use this medication regularly in order to get the most benefit from it. To help you remember, use it at the same time each day. Do not take potassium supplements or salt substitutes containing potassium without talking to your doctor or pharmacist first. This medicine can raise your potassium levels, which rarely can cause serious side effects such as muscle weakness or very slow heartbeats. Tell your doctor immediately if these effects occur. The dosage is based on your medical condition and response to therapy. For the treatment of high blood pressure, it may take 4 weeks before the full benefit of this drug occurs. It is important to continue taking this medication even if you feel well. Most people with high blood pressure do not feel sick.

SIDE EFFECTS: You may experience dizziness, lightheadedness, blurred vision, or back pain as your body adjusts to the medication. If any of these effects persist or worsen, notify your doctor or pharmacist promptly. Tell your doctor immediately if any of these unlikely but serious side effects occur: fainting, decreased sexual ability. Tell your doctor immediately if any of these highly unlikely but very serious side effects occur: change in the amount of urine. An allergic reaction to this drug is unlikely, but seek immediate medical attention if it occurs. Symptoms of an allergic reaction include: rash, itching, swelling (especially of the face, lips, tongue, or throat), severe dizziness, trouble breathing. If you notice other effects not listed above, contact your doctor or pharmacist.

WARNING: This drug can cause serious fetal harm (possibly death) if used during the last six months of pregnancy. If you become pregnant or think you may be pregnant, contact your doctor immediately.

Prazosin protects brain

Saturday, November 10th, 2007

PrazosinA drug used for high blood pressure, enlargement of the prostate and as an antipsychotic may protect the brain from stress, U.S. researchers say.

Researchers at Oregon Health & Science University and Portland Veterans Affairs Medical Center say Prozosin (brand name Minipress) appears to block the increase of steroid hormones known as glucocorticoids. Elevated levels of these hormones are linked to atrophy of nerve branches and nerve cell death.

“It’s known, from human studies, that corticosteroids are not good for you cognitively,” study co-author, Dr. S. Paul Berger, said in a statement. “We think prazosin protects the brain from being damaged by excessive levels of corticosteroid stress hormones.”

The researchers said high levels of glucocorticoids in blood serum are associated with such psychiatric conditions as schizophrenia, depression, post-traumatic stress syndrome and Alzheimer’s disease and are linked to decreases in cognitive performance in older people not suffering from clinical dementia.

The study was presented at the annual Society for Neuroscience conference in San Diego.

Prazosin drug helps posttraumatic stress disorder nightmares

A generic drug already used by millions of Americans for high blood pressure and prostate problems has been found to improve sleep and lessen trauma nightmares in veterans with posttraumatic stress disorder (PTSD).

“This is the first drug that has been demonstrated effective for PTSD nightmares and sleep disruption,” said Murray A. Raskind, MD, executive director of the mental health service at the Veterans Affairs Puget Sound Health Care System and lead author of a study appearing April 15 in Biological Psychiatry.

The randomized trial of 40 veterans compared a nightly dose of prazosin (PRAISE-oh-sin) with placebo over eight weeks. Participants continued to take other prescribed medications over the course of the trial.

At the end of the study, veterans randomized to prazosin reported significantly improved sleep quality, reduced trauma nightmares, a better overall sense of well being, and an improved ability to function.

“These nighttime symptoms are heavily troublesome to veterans,” said Raskind, who also is director of VA’s VISN 20 (Veterans Integrated Service Network #20) Mental Illness Research, Education and Clinical Centers program (MIRECC). “If you get the nighttime symptoms under control, veterans feel better all around.”

Raskind, also a professor of psychiatry and behavioral sciences at the University of Washington, estimates that of the 10 million U.S. veterans and civilians with PTSD, about half have trauma-related nightmares that could be helped with the drug.

Participants were given 1 mg of prazosin per day for the first three days. The dose was gradually increased over the first four weeks to a maximum of 15 mg at bedtime. The average dose of prazosin in the trial was 13.3 mg. By comparison, typical prazosin doses for controlling blood pressure or treating prostate problems range from 3 mg to 30 mg per day in divided doses.

The drug did not affect blood pressure compared to placebo, though some participants reported transient dizziness when standing from a sitting position during the first weeks of prazosin titration. Other occasional side effects included nasal congestion, headache, and dry mouth, but these were all minor, according to the authors.

“This drug has been taken by many people for decades,” said Raskind. “If there were serious long-term adverse side effects, it is likely we would know about them by now.”

The relatively small size of the study was due to the easy availability of this generic drug, Raskind said. “If you are doing a study with a new drug, the only way people can get it is to be in the study. With prazosin, we have approximately 5,000 veterans with a PTSD diagnosis taking it already in the Northwest alone. So we had to find veterans with PTSD who were not [taking it].”

For treating PTSD, prazosin costs 10 to 30 cents a day at VA contract prices. It is not a sedating sleeping pill, emphasized Raskind. “It does not induce sleep. But once you are asleep, you sleep longer and better.”

And better sleep can make a big difference. “This drug changes lives,” Raskind said. “Nothing else works like prazosin.”

Trauma nightmares appear to arise during light sleep or disruption in REM sleep, whereas normal dreams ,both pleasant and unpleasant, occur during normal REM sleep. Prazosin works by blocking the brain’s response to the adrenaline-like neurotransmitter norepinephrine. Blocking norepinephrine normalizes and increases REM sleep. In this study, veterans taking prazosin reported that they resumed normal dreaming.

One dose of prazosin works for 6 to 8 hours. Unlike similar drugs, prazosin does not induce tolerance; people can take it for years without increasing the dose. But when veterans stop taking it, Raskind said, the trauma nightmares usually return.

Aside from the VA-funded study he just published, Raskind is working on three larger studies of prazosin. One, a VA cooperative study slated to start this month, will enroll about 300 veterans at 12 VA facilities. The second, a collaborative study with Walter Reed Army Medical Center and Madigan Army Medical Center, will enroll active-duty soldiers who have trauma nightmares. The third study, funded by the National Institute of Mental Health, will look at prazosin in the treatment of civilian trauma PTSD.

Why is this medication prescribed?

Prazosin is used alone or in combination with other medications to treat high blood pressure. Prazosin is in a class of medications called alpha-blockers. It works by relaxing the blood vessels so that blood can flow more easily through the body.

How should this medicine be used?

Prazosin comes as a capsule to take by mouth. It usually is taken two or three times a day at evenly spaced intervals. The first time taking prazosin, you should take it before you go to bed. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take prazosin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Your doctor will probably start you on a low dose of prazosin and gradually increase your dose.

Prazosin controls high blood pressure but does not cure it. Continue to take prazosin even if you feel well. Do not stop taking prazosin without talking to your doctor.

Other uses for this medicine

Prazosin is also used to treat benign prostatic hyperplasia (BPH, noncancerous enlargement of the prostate), congestive heart failure, pheochromocytoma (adrenal gland tumor), and Raynaud’s disease (condition where the fingers and toes change skin color from white to blue to red when exposed to hot or cold temperatures). Talk to your doctor about the possible risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

What side effects can this medication cause? Return to top

Prazosin may cause side effects. Tell your doctor if any of these symptoms or those listed in the SPECIAL PRECAUTIONS section are severe or do not go away:

  • weakness
  • tiredness
  • headache
  • nausea

Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately:

  • hives
  • rash
  • itching
  • difficulty breathing
  • fast, pounding, or irregular heartbeat
  • chest pain
  • painful erection of the penis that lasts for hours

Brand name - Minipress®

Rates of high cholesterol problems among young people increase

Tuesday, October 30th, 2007

Cholesterol drugsUse of cholesterol and blood pressure medicines by young adults appears to be rising rapidly — at a faster pace than among senior citizens, according to an industry report being released Tuesday.

Experts point to higher rates of obesity, high blood pressure and high cholesterol problems among young people. Also, doctors are getting more aggressive with preventive treatments.

“This is good news, that more people in this age range are taking these medicines,” said Dr. Daniel W. Jones, president of the American Heart Association.

Still, he said many more people should be on the drugs that lower cholesterol or blood pressure and which have been shown to reduce risks for heart attack and stroke.

The new data, from prescription benefit manager Medco Health Solutions Inc., indicate use of cholesterol-lowering drugs among people aged 20 to 44, while still low, jumped 68 percent over a six-year period.

The rate rose from 2.5 percent in 2001 to just over 4 percent in 2006 among Medco customers. That means roughly 4.2 million Americans in that age group are now taking cholesterol medicines.

Meanwhile, use of blood pressure medicines increased 21 percent, from about 7 percent of 20- to 44-year-olds in 2001 to over 8 percent in 2006. That translates into about 8.5 million Americans in that age group taking drugs to lower their blood pressure.

“It was a surprise to us,” said Dr. Robert Epstein, chief medical officer at Franklin Lakes, N.J.-based Medco. “Maybe the fact that we’re seeing more young people with high cholesterol and blood pressure is indicative of the epidemic of obesity and overweight that we’re seeing in this country.”

Among people 65 and older, use of blood pressure drugs increased only 9.5 percent and use of cholesterol drugs by 52 percent. That’s because half the seniors were already taking blood pressure drugs and more than one in four were taking cholesterol drugs in 2001.

Jones, dean of the University of Mississippi School of Medicine, said he has seen some increase in young adults with blood pressure or cholesterol problems, but not of the magnitude suggested by Medco’s data.

Dr. Howard Weintraub, the heart disease prevention expert at the American College of Cardiology, said he’s “thrilled” by the dramatic increase, which he says is tied to requests from patients with “a brand new sense of urgency” and referrals from other doctors to his private practice.

“If you wait until a heart attack or stroke, it’s a little bit late,” Weintraub said.

He and Epstein both said patients with problems should first work with their doctors on lifestyle changes — more exercise, a better diet and weight loss. But Weintraub said many people need medication to achieve and maintain the ever-lower levels of blood pressure and cholesterol that experts now recommend.

However, Dr. John LaRosa, president of SUNY Downstate Medical Center, said, “particularly for young people, lifestyle change is worth a try.”

Once patients start taking these medicines, they usually stay with them and there are some side effects, LaRosa said.

“It’s amazing what (losing) five or 10 pounds will do” to reduce blood pressure and cholesterol levels, he said.

Federal health statistics show that while the percentage of people with high cholesterol has dropped overall in recent years, it has risen among younger people, especially those 20 to 34 years old.

Meanwhile, the prevalence of high blood pressure was flat or up slightly among those age groups; among women in the 35 to 44 age group, the rate of high blood pressure rose significantly.

Medco processes prescription claims for about 60 million insured Americans. The report’s findings are based on a representative sample of data from 2.5 million members.

Increase in use of cholesterol and hypertension medications largest among people ages 20 to 44Drop in the age of women using heart disease medications greater than men

Heart disease, high blood pressure and hardening of the arteries - conditions that are usually associated with the senior population - are creeping into young adulthood. According to new research conducted by Medco Health Solutions, Inc. , prescription drug use by younger adults for heart disease- related conditions is increasing at a rapid rate, far outpacing older adults and offering a glimpse into the forthcoming clinical and financial challenges facing the nation’s health care system.

The analysis shows that between 2001 and 2006, the number of 20-44 year olds taking prescription medications to treat high cholesterol increased 68 percent, and use of antihypertensives jumped 21 percent.

Based on this new analysis, the estimated number of 20-44 year olds nationwide on lipid-lowering drugs surged from 2.5 million in 2001 to 4.2 million in 2006, while the number of people of that age taking antihypertensives spiked from 7 million to 8.5 million in the six-year period.

“This may be both a good news, bad news story,” said Dr. Robert Epstein, Medco’s chief medical officer. “The good news is that younger patients are taking medications that control conditions that, if left untreated, could lead to heart attacks and strokes - indicating that physicians are screening patients more regularly and treating these precursors more aggressively than in the past. The bad news is that these conditions are showing up in patients at younger ages, which could be the result of the growing obesity epidemic and various lifestyle factors.”

Not only were the increases among 20-44 year olds significant, but so too were the rates of increase when compared to age groups more traditionally associated with these categories of medications. The increase in the number of 20-44 year-olds on lipid-lowering medications was 37 percent higher than it was for 45 to 64 year olds; the growth in prevalence of those on antihypertensives was 52 percent greater. When compared with patients 65 years or older, the increase in usage of lipid-lowering medications was 31 percent higher in the 20-44 group, and among those on antihypertensives it was more than double.

Decline Seen in Age of Patients on Drug Treatment

The analysis also found a significant shift downward in the age of patients using these drug treatments. In 2006, half of all patients on lipid- lowering drugs were 61 years old or younger; the median age of women fell more sharply than men, dropping from 67 to 62 in the six-year span, as compared to 62 to 59 for men.

The median age of those using antihypertensives declined four years over the six-year period, with half of all patients on these drugs being 60 years or younger in 2006; again women had the greatest decline, dropping from 65 to 60 versus men whose median age fell from 63 to 60.

“There is a history of women being under-diagnosed and under-treated for heart conditions,” said Epstein. “The fact that more women at a younger age are receiving medication treatment for high cholesterol and hypertension is a sign that the medical community is recognizing that heart disease is a serious threat to women as well as men.”

Heart Disease Risks

High cholesterol and high blood pressure are two of the leading risk factors for heart disease, heart attack and stroke. High LDL cholesterol can cause atherosclerosis, a narrowing and hardening of the arteries that feed the heart and brain. High blood pressure, or hypertension, can weaken the arterial walls and make them more prone to atherosclerosis. Both conditions can lead to blood clots that can block blood flow and result in a heart attack or stroke.

For some people with high cholesterol and hypertension, lifestyle changes such as weight loss, dietary changes and exercise can control the conditions. For others, medications may be needed. The most common medications used to treat high cholesterol are statins. To treat hypertension, diuretics, beta- blockers and ACE inhibitors are often prescribed.